相关实验视频
Updated: Jul 25, 2026

12:30
Monitoring ER/SR Calcium Release with the Targeted Ca2+ Sensor CatchER+
Published on: May 19, 2017
在确定通道激活动力学方面,二皮里丁受体的重复I是至关重要的
1Department of Medical Chemistry, Kyoto University Faculty of Medicine, Japan.
Nature
|August 29, 1991
概括
重复I的通道控制了它们的激活速度. 这一发现揭示了电压通道的结构变化如何影响其功能,从而区分骨和心脏肌肉类型.
科学领域:
- 分子生物学分子生物学
- 生物物理学的生物物理.
- 心血管生理学心血管生理学
背景情况:
- 离子通道激活涉及结构变化.
- 电压通道 (VGCC) 具有一个共同的结构图案,具有四个同源重复 (I-IV).
- 每个重复包含一个电压感应的S4段,表明重复在激活中的特定角色.
研究的目的:
- 为了研究VGCC激活的分子基础.
- 确定哪种结构重复决定了骨和心脏通道的独特激活动态.
主要方法:
- 构建编码化马体Ca2+通道的互补DNA.
- 在骨和心脏二胺基因受体之间交换同源重复 (I-IV).
- 在表达的基马体道中分析激活动力学.
主要成果:
- 化学Ca2+通道已经成功构建.
- 重复我被确定为激活速度的决定因素.
- 从骨肌肉受体用心脏对应物取代重复I导致了快速的,类似心脏的激活.
结论:
- 对于确定Ca2+通道激活率而言,二皮里丁受体的第一个重复 (重复I) 是至关重要的.
- 这一发现阐明了骨和心肌道之间的差异激活动力学的结构基础.
- 重复我在底层的道门的构造转换中发挥着关键作用.
相关概念视频
G-Protein Gated Ion Channels
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Sensory organs,...
Feedback Regulation of Calcium Concentration
Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

